The Current Ratio as of November 2024 (TTM) for Mind Medicine (MindMed) Inc. (MNMD) is 5.92

According to Mind Medicine (MindMed) Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.92. This represents a change of 40.02% compared to the average of 4.23 of the last 4 quarters.

Mind Medicine (MindMed) Inc. (MNMD) Historical Current Ratio (quarterly & annually)

How has MNMD Current Ratio performed in the past?

The mean historical Current Ratio of Mind Medicine (MindMed) Inc. over the last ten years is 15.48. The current 5.92 Current Ratio has changed 3.72% with respect to the historical average. Over the past ten years (40 quarters), MNMD's Current Ratio was at its highest in in the December 2020 quarter at 27.10. The Current Ratio was at its lowest in in the September 2019 quarter at 0.

Mind Medicine (MindMed) Inc. (MNMD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mind Medicine (MindMed) Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mind Medicine (MindMed) Inc. (MNMD) Average Current Ratio

How has MNMD Current Ratio performed in the past?

The current Current Ratio of Mind Medicine (MindMed) Inc. (MNMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mind Medicine (MindMed) Inc. (MNMD) Current Ratio vs. Peers

How is MNMD’s Current Ratio compared to its peers?

Mind Medicine (MindMed) Inc.’s Current Ratio is less than Cybin Inc. (41.70), greater than Seelos Therapeutics, Inc. (0.08), less than GH Research PLC (19.60), greater than Awakn Life Sciences Corp. (0.35), less than Atai Life Sciences N.V. (6.68), greater than Freeline Therapeutics Holdings plc (1.95), greater than Bio-Path Holdings, Inc. (1.67), greater than Vaccinex, Inc. (0.42), less than Eliem Therapeutics, Inc. (60.41), greater than Opthea Limited (2.94), less than Molecular Partners AG (14.58), less than Edgewise Therapeutics, Inc. (30.24), less than iTeos Therapeutics, Inc. (18.08), greater than Checkpoint Therapeutics, Inc. (0.26), greater than Mustang Bio, Inc. (0.46), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Fortress Biotech, Inc. (1.37), less than Kodiak Sciences Inc. (10.59),

Build a custom stock screener for Mind Medicine (MindMed) Inc. (MNMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mind Medicine (MindMed) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mind Medicine (MindMed) Inc. (MNMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mind Medicine (MindMed) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.